Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel daily dosing and effects on ovulation and bleeding in healthy women
2018-002700-14Phase 2Completed
- Sponsor
- Navad Life Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of avatrombopag in None, sponsored by Navad Life Sciences. Primary endpoint: Primary pharmacodynamic parameter. Started Oct 2018; status: completed.
02
Drugs
avatrombopag
Beyond the preview
Go deeper on 2018-002700-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002700-14.